Clearside Biomedical ( $CLSD )

Recent earnings result

1. Clearside Biomedical EPS misses by $0.03, misses on revenue

Events & Annual meetings

There are no events at this time for this stock.

For list of CLSD events, you may visit their Investor Relations website.

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside’s proprietary SCS Microinjector™ targeting the suprachoroidal space (SCS®) offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company’s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations such as gene therapy.

For list of CLSD events, you may visit their Investor Relations website.

Recent results

• $FOSL - Fossil Inc.
  

  Fossil tracks higher after earnings

• $BNR - Burning Rock Biotech
  

  Burning Rock Biotech EPS misses by $0.04, beats on revenue

• $BEST - BEST Inc
  

  BEST EPS misses by $0.11, misses on revenue

• $FRG - Franchise Group
  

  Franchise Group EPS beats by $0.02, misses on revenue

• $FNV - Franco-Nevada Corp
  

  Franco-Nevada EPS beats by $0.16, beats on revenue

• $KNOP - KNOT Offshore Partners LP
  

  KNOT Offshore Partners misses on revenue

• $HOFV - Hall Of Fame Resort
  

  Hall of Fame Resort & Entertainment Company EPS misses by $1.26, misses on revenue

• $GDS - GDS Holdings
  

  GDS Holdings EPS beats by $0.04, misses on revenue

• $LTRN - Lantern Pharma
  

  Lantern Pharma EPS misses by $0.02

• $AMOT - Allied Motion Technologies Inc.
  

  Allied Motion Technologies EPS beats by $0.03, beats on revenue